- Companies in the index
- 349
Venture capital firm investing across technology and healthcare.
Read the Canaan Partners profilePortfolio Company · Operating Co.
Who owns Rallybio?
Rallybio is listed as an exited portfolio company of Canaan Partners on Canaan Partners' own portfolio page.
From the company's website
Despite science’s best efforts, treatments for rare diseases have greatly lagged behind patient needs. It’s time to tackle the undone, the too difficult…
Source: rallybio.com, read November 2026
Company Snapshot
Rallybio is a Healthcare company. Its owner on record, Canaan Partners, is a firm. Canaan Partners lists 349 companies in the index, 17 of them in Healthcare.
About the owner
Questions about Rallybio
Who owns Rallybio?
Rallybio is listed as an exited portfolio company of Canaan Partners on Canaan Partners' own portfolio page.
What sector is Rallybio in?
Rallybio is in Healthcare. Classified from the company's own description.
What else does Canaan Partners own in Healthcare?
Canaan Partners lists 16 other Healthcare companies in the index, including Acesion Pharma ApS, Agomab Therapeutics, Alphina Therapeutics, Alterome Therapeutics, Inc. and Amicus Therapeutics.
What is Rallybio's website?
Rallybio's website is https://rallybio.com/.
Sources
This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Rallybio and does not provide investment advice.
Other portfolio companies of Canaan Partners
6 of 348 shown
See the full Canaan Partners portfolio.
Other Healthcare companies held by Canaan Partners
Other Healthcare portfolio companies
101 Mobility
via Cortec Group
123Dentist
via KKR
32co
via Wavemaker 360 Health
3P Biopharmaceuticals
via Eurazeo
3Shape
via EQT Partners
6n Systems
via Marlin Equity Partners
98point6
via L Catterton
A Place for Mom
via Silver Lake
Browse PE-backed companies.